Fundamentals data is not available for this company.
No recent information was found.
Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
Currency | US Dollars |
Share Price | $ 27.87 |
Change Today | $ 0.48 |
% Change | 1.75 % |
52 Week High | $28.28 |
52 Week Low | $27.38 |
Volume | 2,246,054 |
Shares Issued | 156.88m |
Market Cap | $4,372.31m |
Beta | 0.00 |
RiskGrade | 248 |
Time | Volume / Share Price |
16:00 | 411,555 @ $27.87 |
16:00 | 348 @ $27.89 |
15:59 | 216 @ $27.89 |
15:59 | 100 @ $27.89 |
15:59 | 100 @ $27.89 |
You are here: research